Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Share:
Related FRX
Icahn's (Potential) Move Into Biotech
Carl Icahn's Track Record In Big Pharma
Related ENDP
Imprimis Spins Off Eton Pharmaceuticals To Challenge Pricey Pipelines Of Mallinckrodt, Endo
Why Is Endo (ENDP) Down 4.7% Since the Last Earnings Report?

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX) is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%.

The trailing-twelve-month revenue at Endo Health Solutions (NASDAQ: ENDP) is $3.03 billion. Endo Health's PEG ratio is 0.90.

The trailing-twelve-month revenue at Warner Chilcott plc (NASDAQ: WCRX) is $2.58 billion. Warner Chilcott had $304.00 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Dr. Reddy's Laboratories (NYSE: RDY) is $2.05 billion. Dr. Reddy's operating margin for the same period is 20.84%.

Posted-In: Drug Manufacturers-Other Industry Highest Revenue Mid-CapTrading Ideas

 

Related Articles (ENDP + FRX)

View Comments and Join the Discussion!